Vaxart Inc
Change company Symbol lookup
Select an option...
VXRT Vaxart Inc
ASO Academy Sports & Outdoors Inc
AAPL Apple Inc
RJF Raymond James Financial Inc
BHP BHP Group Ltd
COPX Global X Copper Miners ETF
QOEG Quality Online Education Group Inc
VCVCU 10X Capital Venture Acquisition Corp
JRJC China Finance Online Co Ltd
CRM Salesforce.Com Inc

Health Care : Biotechnology | Small Cap Blend
Company profile

Vaxart, Inc., formerly Aviragen Therapeutics, Inc., is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The Company has three product candidates in clinical development that address viral infections that have limited therapeutic options. Its products include vapendavir, an oral treatment for human rhinovirus (HRV) upper respiratory infections in moderate-to-severe asthmatics in Phase IIb SPIRITUS trial; BTA585, an oral fusion (F) protein inhibitor in Phase II development for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in Phase II development for condyloma caused by human papillomavirus Types 6 and 11. It has preclinical RSV non-fusion inhibitor program. It has focused its research and drug development capabilities on discovering and developing small molecule compounds that can prevent or treat infectious diseases.


Last Trade
-0.11 (-1.41%)
B/A Size

Market Hours

Closing Price
Day's Change
-0.93 (-10.64%)
Bid close
Ask close
B/A Size
Day's High
Day's Low

10-day average volume:
  • Prev Close
  • Today's Open
  • Day's Range
  • Avg Vol (10-day)
  • Last (time)
    3:59p ET 06/15/21
  • Last (size)
  • 52-Wk Range
    2.26 - 24.90
  • (06/15/20 - 02/02/21)
  • 192.5%
  • Market Cap
  • Shares Outstanding
  • -0.46
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.3
  • 37.82
  • (% of float 05/28/21)

Latest News

June 07, 2021
9:00 am ET
Globe Newswire
May 27, 2021
8:00 am ET
Globe Newswire
May 07, 2021
8:00 am ET
Globe Newswire
May 04, 2021
8:00 am ET
Globe Newswire
May 03, 2021
5:06 pm ET
Globe Newswire
8:00 am ET
Globe Newswire
April 29, 2021
8:21 am ET
Globe Newswire
April 26, 2021
8:01 am ET
Globe Newswire
April 23, 2021
8:00 am ET
Globe Newswire
April 22, 2021
8:00 am ET
Globe Newswire
March 24, 2021
9:00 am ET
PR Newswire
March 23, 2021
9:00 am ET
PR Newswire
March 04, 2021
10:27 am ET
February 03, 2021
10:13 am ET
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.